Niels Høiby
Niels Høiby
Professor in Medical Microbiology, Universirty of Copenhagen, past chairman, Department of Clinical
Dirección de correo verificada de
Citado por
Citado por
Antibiotic resistance of bacterial biofilms
N Høiby, T Bjarnsholt, M Givskov, S Molin, O Ciofu
International journal of antimicrobial agents 35 (4), 322-332, 2010
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
M Hentzer, H Wu, JB Andersen, K Riedel, TB Rasmussen, N Bagge, ...
The EMBO journal 22 (15), 3803-3815, 2003
Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound
M Hentzer, K Riedel, TB Rasmussen, A Heydorn, JB Andersen, ...
Microbiology 148 (1), 87-102, 2002
Why chronic wounds will not heal: a novel hypothesis
T Bjarnsholt, K Kirketerp‐Møller, PØ Jensen, KG Madsen, R Phipps, ...
Wound repair and regeneration 16 (1), 2-10, 2008
The clinical impact of bacterial biofilms
N Høiby, O Ciofu, HK Johansen, Z Song, C Moser, PØ Jensen, S Molin, ...
International journal of oral science 3 (2), 55-65, 2011
Strategies for combating bacterial biofilm infections
H Wu, C Moser, HZ Wang, N Høiby, ZJ Song
International journal of oral science 7 (1), 1-7, 2015
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
T Bjarnsholt, PØ Jensen, MJ Fiandaca, J Pedersen, CR Hansen, ...
Pediatric pulmonology 44 (6), 547-558, 2009
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
G Doring, SP Conway, HG Heijerman, ME Hodson, N Hoiby, A Smyth, ...
European Respiratory Journal 16 (4), 749-767, 2000
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
N H⊘ iby, O Ciofu, T Bjarnsholt
Future microbiology 5 (11), 1663-1674, 2010
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
A Folkesson, L Jelsbak, L Yang, HK Johansen, O Ciofu, N Høiby, S Molin
Nature Reviews Microbiology 10 (12), 841-851, 2012
ESCMID guideline for the diagnosis and treatment of biofilm infections 2014
N Høiby, T Bjarnsholt, C Moser, GL Bassi, T Coenye, G Donelli, ...
Clinical microbiology and infection 21, S1-S25, 2015
The in vivo biofilm
T Bjarnsholt, M Alhede, M Alhede, SR Eickhardt-Sørensen, C Moser, ...
Trends in microbiology 21 (9), 466-474, 2013
Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed …
N Hoiby, EW Flensborg, B Beck, B Friis, SV Jacobsen, L Jacobsen
Scandinavian journal of respiratory diseases 58 (2), 65-79, 1977
OXA-type carbapenemases
J Walther-Rasmussen, N Høiby
Journal of antimicrobial chemotherapy 57 (3), 373-383, 2006
Distribution, organization, and ecology of bacteria in chronic wounds
K Kirketerp-Møller, PØ Jensen, M Fazli, KG Madsen, J Pedersen, C Moser, ...
Journal of clinical microbiology 46 (8), 2717-2722, 2008
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent
T Bjarnsholt, PØ Jensen, M Burmølle, M Hentzer, JAJ Haagensen, ...
Microbiology 151 (2), 373-383, 2005
Mucoid conversion of Pseudomonas aeruginos by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung
K Mathee, O Ciofu, C Sternberg, PW Lindum, JIA Campbell, P Jensen, ...
Microbiology 145 (6), 1349-1357, 1999
Applying insights from biofilm biology to drug development—can a new approach be developed?
T Bjarnsholt, O Ciofu, S Molin, M Givskov, N Høiby
Nature reviews Drug discovery 12 (10), 791-808, 2013
Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
B Frederiksen, C Koch, N Høiby
Pediatric pulmonology 23 (5), 330-335, 1997
Pathogenesis of cystic fibrosis.
C Koch, N Hoiby
The Lancet 341 (8852), 1065-1069, 1993
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20